Release Date: 06/07/10 08:26 Summary: Appendix 3B-Non Renounceable Option Issue Price Sensitive: No Download Document 48.59KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling